T. Rowe Price Associates’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $742K | Buy |
|
|||||
|
2025
Q2 | $396K | Buy |
|
|||||
|
2025
Q1 | $316K | Buy |
|
|||||
|
2024
Q4 | $386K | Buy |
|
|||||
|
2024
Q3 | $397K | Buy |
|
|||||
|
2024
Q2 | $0 | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.1M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $20.3M | Buy |
|
|||||
|
2014
Q4 | $19.3M | Buy |
|
|||||
|
2014
Q3 | $6.61M | Buy |
|